ANDREW GUGGENHIME Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANDREW GUGGENHIME.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANDREW GUGGENHIME. ANDREW GUGGENHIME is CFO in NEOFORMA INC ($NEOF) and Chief Financial Officer in NEOFORMA INC ($NEOF) and CFO in Dermira, Inc. ($DERM) and COO and CFO in Dermira, Inc. ($DERM) and President and CFO in Vaxcyte, Inc. ($PCVX).
Latest Insider Trading Transactions of ANDREW GUGGENHIME
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DERM, NEOF, PCVX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 06 2021 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | President and CFO | Option Exercise | A | 20.93 | 145,000 | 3,034,850 | 145,000 | |
Feb 24 2020 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | D | 0.00 | 15,000 | 0 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | D | 0.00 | 25,000 | 0 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | D | 0.00 | 5,700 | 0 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | D | 0.00 | 3,562 | 0 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | D | 7.42 | 65,000 | 482,300 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | D | 28.25 | 57,000 | 1,610,250 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | D | 33.84 | 71,250 | 2,411,100 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | D | 26.37 | 71,250 | 1,878,863 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | D | 16.00 | 67,240 | 1,075,840 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | D | 16.00 | 73,287 | 1,172,592 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | D | 5.51 | 121 | 667 | 0 | |
Feb 24 2020 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Sell | D | 18.75 | 41,951 | 786,581 | 0 | 42 K to 0 (-100.00 %) |
Aug 19 2019 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | M | 0.00 | 3,562 | 0 | 0 | |
Aug 19 2019 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | M | 0.00 | 2,850 | 0 | 5,700 | |
Aug 19 2019 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | M | 0.00 | 3,563 | 0 | 3,562 | |
Aug 19 2019 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Payment of Exercise | F | 7.91 | 1,232 | 9,745 | 40,927 | 42.2 K to 40.9 K (-2.92 %) |
Aug 19 2019 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Payment of Exercise | F | 7.91 | 1,233 | 9,753 | 42,159 | 43.4 K to 42.2 K (-2.84 %) |
Aug 19 2019 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Payment of Exercise | F | 7.91 | 986 | 7,799 | 43,392 | 44.4 K to 43.4 K (-2.22 %) |
Aug 19 2019 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Buy | M | 0.00 | 3,562 | 0 | 44,378 | 40.8 K to 44.4 K (+8.73 %) |
Aug 19 2019 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Buy | M | 0.00 | 3,563 | 0 | 40,816 | 37.3 K to 40.8 K (+9.56 %) |
Aug 19 2019 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Buy | M | 0.00 | 2,850 | 0 | 37,253 | 34.4 K to 37.3 K (+8.28 %) |
May 21 2019 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
May 21 2019 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Payment of Exercise | F | 10.50 | 8,645 | 90,773 | 34,403 | 43 K to 34.4 K (-20.08 %) |
May 21 2019 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Buy | M | 0.00 | 25,000 | 0 | 43,048 | 18 K to 43 K (+138.52 %) |
Feb 14 2019 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Feb 14 2019 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | CFO | Option Exercise | A | 7.42 | 65,000 | 482,300 | 65,000 | |
Aug 17 2018 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | M | 0.00 | 3,563 | 0 | 3,562 | |
Aug 17 2018 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | M | 0.00 | 3,562 | 0 | 7,125 | |
Aug 17 2018 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | M | 0.00 | 950 | 0 | 8,550 | |
Aug 17 2018 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Aug 17 2018 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Payment of Exercise | F | 9.58 | 1,233 | 11,812 | 16,496 | 17.7 K to 16.5 K (-6.95 %) |
Aug 17 2018 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Payment of Exercise | F | 9.58 | 1,232 | 11,803 | 17,729 | 19 K to 17.7 K (-6.50 %) |
Aug 17 2018 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Payment of Exercise | F | 9.58 | 329 | 3,152 | 18,961 | 19.3 K to 19 K (-1.71 %) |
Aug 17 2018 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Buy | M | 0.00 | 3,563 | 0 | 19,290 | 15.7 K to 19.3 K (+22.66 %) |
Aug 17 2018 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Buy | M | 0.00 | 3,562 | 0 | 15,727 | 12.2 K to 15.7 K (+29.28 %) |
Aug 17 2018 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Buy | M | 0.00 | 950 | 0 | 12,165 | 11.2 K to 12.2 K (+8.47 %) |
Feb 16 2018 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | A | 0.00 | 9,500 | 0 | 9,500 | |
Feb 16 2018 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | A | 28.25 | 57,000 | 1,610,250 | 57,000 | |
Aug 17 2017 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | M | 0.00 | 3,562 | 0 | 7,125 | |
Aug 17 2017 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | M | 0.00 | 1,188 | 0 | 10,687 | |
Aug 17 2017 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Payment of Exercise | F | 23.58 | 447 | 10,540 | 10,073 | 10.5 K to 10.1 K (-4.25 %) |
Aug 17 2017 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Payment of Exercise | F | 23.58 | 1,339 | 31,574 | 10,520 | 11.9 K to 10.5 K (-11.29 %) |
Aug 17 2017 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Buy | M | 0.00 | 1,188 | 0 | 11,859 | 10.7 K to 11.9 K (+11.13 %) |
Aug 17 2017 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Buy | M | 0.00 | 3,562 | 0 | 10,671 | 7.1 K to 10.7 K (+50.11 %) |
Feb 22 2017 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | A | 0.00 | 11,875 | 0 | 11,875 | |
Feb 22 2017 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | A | 33.84 | 71,250 | 2,411,100 | 71,250 | |
Nov 10 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | M | 5.51 | 4,100 | 22,591 | 120,513 | |
Nov 10 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Sell | S | 35.02 | 4,100 | 143,582 | 5,116 | 9.2 K to 5.1 K (-44.49 %) |
Nov 10 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Buy | M | 5.51 | 4,100 | 22,591 | 9,216 | 5.1 K to 9.2 K (+80.14 %) |
Oct 13 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | M | 5.51 | 10,900 | 60,059 | 124,613 | |
Oct 13 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Sell | S | 35.13 | 1,605 | 56,384 | 5,116 | 6.7 K to 5.1 K (-23.88 %) |
Oct 13 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Sell | S | 34.20 | 9,295 | 317,889 | 6,721 | 16 K to 6.7 K (-58.04 %) |
Oct 13 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Buy | M | 5.51 | 10,900 | 60,059 | 16,016 | 5.1 K to 16 K (+213.06 %) |
Sep 20 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | M | 5.51 | 15,000 | 82,650 | 135,513 | |
Sep 20 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Sell | S | 35.01 | 15,000 | 525,150 | 5,116 | 20.1 K to 5.1 K (-74.57 %) |
Sep 20 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Buy | M | 5.51 | 15,000 | 82,650 | 20,116 | 5.1 K to 20.1 K (+293.20 %) |
Sep 14 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | M | 5.51 | 10,000 | 55,100 | 150,513 | |
Sep 14 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Sell | S | 32.53 | 10,000 | 325,300 | 5,116 | 15.1 K to 5.1 K (-66.16 %) |
Sep 14 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Buy | M | 5.51 | 10,000 | 55,100 | 15,116 | 5.1 K to 15.1 K (+195.47 %) |
Aug 16 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | M | 0.00 | 1,188 | 0 | 10,687 | |
Aug 16 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Payment of Exercise | F | 31.59 | 447 | 14,121 | 5,116 | 5.6 K to 5.1 K (-8.04 %) |
Aug 16 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Buy | M | 0.00 | 1,188 | 0 | 5,563 | 4.4 K to 5.6 K (+27.15 %) |
Aug 12 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | M | 5.51 | 10,000 | 55,100 | 160,513 | |
Aug 12 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Sell | S | 31.02 | 10,000 | 310,174 | 4,375 | 14.4 K to 4.4 K (-69.57 %) |
Aug 12 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Buy | M | 5.51 | 10,000 | 55,100 | 14,375 | 4.4 K to 14.4 K (+228.57 %) |
Jul 12 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | M | 5.51 | 10,000 | 55,100 | 170,513 | |
Jul 12 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Sell | S | 29.80 | 2,639 | 78,642 | 4,375 | 7 K to 4.4 K (-37.62 %) |
Jul 12 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Sell | S | 30.28 | 7,361 | 222,891 | 7,014 | 14.4 K to 7 K (-51.21 %) |
Jul 12 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Buy | M | 5.51 | 10,000 | 55,100 | 14,375 | 4.4 K to 14.4 K (+228.57 %) |
Feb 09 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | A | 0.00 | 11,875 | 0 | 11,875 | |
Feb 09 2016 | DERM | Dermira, Inc. | GUGGENHIME ANDREW | COO and CFO | Option Exercise | A | 26.37 | 71,250 | 1,878,863 | 71,250 | |
Mar 24 2005 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 65,255 | 55.3 K to 65.3 K (+18.10 %) |
Sep 14 2004 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | Chief Financial Off ... | Sell | S | 10.00 | 500 | 5,000 | 54,476 | 55 K to 54.5 K (-0.91 %) |
Sep 01 2004 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | Chief Financial Off ... | Sell | S | 10.00 | 500 | 5,000 | 54,976 | 55.5 K to 55 K (-0.90 %) |
Aug 03 2004 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | Chief Financial Off ... | Buy | P | 5.70 | 1,373 | 7,819 | 55,476 | 54.1 K to 55.5 K (+2.54 %) |
Jul 13 2004 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | Chief Financial Off ... | Sell | S | 10.95 | 500 | 5,475 | 54,103 | 54.6 K to 54.1 K (-0.92 %) |
Jun 18 2004 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | Chief Financial Off ... | Sell | S | 11.95 | 500 | 5,975 | 54,603 | 55.1 K to 54.6 K (-0.91 %) |
Jun 18 2004 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | Chief Financial Off ... | Sell | S | 11.95 | 500 | 5,975 | 54,603 | 55.1 K to 54.6 K (-0.91 %) |
Jun 10 2004 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | Chief Financial Off ... | Sell | S | 11.62 | 500 | 5,810 | 55,103 | 55.6 K to 55.1 K (-0.90 %) |
May 12 2004 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | Chief Financial Off ... | Sell | S | 12.35 | 1,000 | 12,350 | 55,603 | 56.6 K to 55.6 K (-1.77 %) |
Feb 24 2004 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | Chief Financial Off ... | Option Exercise | A | 11.10 | 45,200 | 501,720 | 45,200 | |
Feb 24 2004 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | Chief Financial Off ... | Grant | A | 0.00 | 20,900 | 0 | 56,603 | 35.7 K to 56.6 K (+58.54 %) |
Feb 24 2004 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | Chief Financial Off ... | Option Exercise | A | 11.10 | 45,200 | 501,720 | 45,200 | |
Feb 24 2004 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | Chief Financial Off ... | Grant | A | 0.00 | 20,900 | 0 | 56,603 | 35.7 K to 56.6 K (+58.54 %) |
Feb 03 2004 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | Chief Financial Off ... | Buy | P | 5.70 | 1,053 | 5,997 | 35,703 | 34.7 K to 35.7 K (+3.04 %) |
Feb 03 2004 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | Chief Financial Off ... | Buy | P | 5.70 | 1,053 | 5,997 | 35,703 | 34.7 K to 35.7 K (+3.04 %) |
Aug 04 2003 | NEOF | NEOFORMA INC | GUGGENHIME ANDREW | CFO | Buy | P | 5.70 | 2,226 | 12,677 | 34,650 | 32.4 K to 34.7 K (+6.87 %) |
Page: 1